Western Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Western Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,756	Closed	-$201K	–	713
2023 Q3	$201K	Buy	+2,756	New	+$220K	0.02%	614
2022 Q4	–	Sell	-4,380	Closed	-$347K	–	805
2022 Q3	$347K	Buy	4,380 +1,360	+45%	+$115K	0.02%	593
2022 Q2	$221K	Sell	3,020 -301	-9%	-$22.6K	0.01%	708
2022 Q1	$298K	Buy	+3,321	New	+$307K	0.01%	679
2021 Q2	–	Sell	-2,057	Closed	-$279K	–	636
2021 Q1	$279K	Buy	+2,057	New	+$308K	0.04%	421
2020 Q1	–	Sell	-2,380	Closed	-$226K	–	429
2019 Q4	$226K	Buy	+2,380	New	+$206K	0.03%	364
2019 Q3	–	Sell	-2,270	Closed	-$200K	–	428
2019 Q2	$200K	Sell	2,270 -105	-4%	-$8.96K	0.03%	391
2019 Q1	$215K	Buy	+2,375	New	+$202K	0.05%	353

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Western Wealth Management's XBI Position: Q4 2023 in Review

Western Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 2,756 shares — an estimated $201K sold.

Western Wealth Management first reported a position in XBI in Q1 2019 and held it in 8 quarters. The position peaked at $347K in Q3 2022. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Western Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
Western Wealth Management sold 2,756 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $201K.
Western Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 8 quarters.
Western Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $347K in Q3 2022.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Western Wealth Management's 13F filing for Q4 2023, filed 31 Jan 2024.